Subscribe To Our Free Newsletter |
Neutral on Eris Lifesciences, target price Rs 930: Motilal Oswal
Eris Lifesciences Ltd. key Products/Revenue Segments include Pharmaceuticals and Other Operating Revenue for the year ending 31-Mar-2023.